Ketoconazole description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Ketoconazole

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING

WARNING
WARNINGSPRECAUTIONS
CONTRAINDICATIONSWARNINGSPRECAUTIONS
CONTRAINDICATIONSWARNINGSPRECAUTIONS
CONTRAINDICATIONSWARNINGSPRECAUTIONS

KETOCONAZOLE DESCRIPTION



Ketoconazole

CLINICAL PHARMACOLOGY




Mode of Action


INDICATIONS & USAGE




KETOCONAZOLE CONTRAINDICATIONS

BOX WARNINGWARNINGSPRECAUTIONS
BOX WARNINGWARNINGSPRECAUTIONS
PRECAUTIONS


WARNINGS

Hepatotoxicity, primarily of the hepatocellular type, has been associated with the use of ketoconazole tablets, including rare fatalities. The reported incidence of hepatotoxicity has been about 1:10,000 exposed patients, but this probably represents some degree of under-reporting, as is the case for most reported adverse reactions to drugs. The median duration of ketoconazole tablet therapy in patients who developed symptomatic hepatotoxicity was about 28 days, although the range extended to as low as 3 days. The hepatic injury has usually, but not always, been reversible upon discontinuation of ketoconazole tablet treatment. Several cases of hepatitis have been reported in children.





BOX WARNINGCONTRAINDICATIONSPRECAUTIONS
BOX WARNINGCONTRAINDICATIONSPRECAUTIONS



PRECAUTIONS

General



INFORMATION FOR PATIENTS

Patients should be instructed to report any signs and symptoms which may suggest liver dysfunction so that appropriate biochemical testing can be done. Such signs and symptoms may include unusual fatigue, anorexia, nausea and/or vomiting, jaundice, dark urine or pale stools (seeWARNINGSsection).

DRUG INTERACTIONS


BOX WARNINGCONTRAINDICATIONSWARNINGS
BOX WARNINGCONTRAINDICATIONSWARNINGS
BOX WARNINGCONTRAINDICATIONSWARNINGS










CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY



PREGNANCY

Teratogenic Effects. Pregnancy Category C



Nonteratogenic Effects




NURSING MOTHERS



PEDIATRIC USE



KETOCONAZOLE ADVERSE REACTIONS

In rare cases, anaphylaxis has been reported after the first doseWARNINGS


BOX WARNINGCONTRAINDICATIONSWARNINGSCONTRAINDICATIONSWARNINGSPRECAUTIONS

OVERDOSAGE

Adults


Children




HOW SUPPLIED











PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Ketoconazole

Ketoconazole

Ketoconazole

Ketoconazole TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-379(NDC:0378-0261)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
KETOCONAZOLE KETOCONAZOLE 200 mg

Inactive Ingredients

Ingredient Name Strength
SILICON DIOXIDE
lactose monohydrate
MAGNESIUM STEARATE
cellulose, microcrystalline
povidone
STARCH, CORN

Product Characteristics

Color Size Imprint Code Shape
white 10 mm M;261 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-379-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA075597 2011-07-14


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.